December 5, 2023

Heart Failure Software Market What Lies Ahead for Global Health

A recent review article published in the Journal of the American College of Cardiology highlights the alarming rise in Cardiovascular Diseases (CVDs), which continue to be the foremost cause of mortality worldwide. According to the report, CVDs accounted for one-third of all global deaths in 2019, with an upward trajectory in incidence and prevalence. China, India, Russia, the United States, and Indonesia bear the highest burden of cardiovascular-related fatalities.

Read More Insights:

The study underscores the urgent need for nations to establish cost-effective public health programs that focus on mitigating cardiovascular risks associated with modifiable behaviors. With prevalent cases expected to surge due to population growth and aging, particularly in regions such as Northern Africa, Western Asia, Central and Southern Asia, Latin America, the Caribbean, and Eastern and Southeastern Asia, the global burden of CVDs is projected to grow exponentially in the coming years. The long-term repercussions of the COVID-19 pandemic are also expected to contribute to this trend.

CVD: America’s Costliest Disease

In the United States, Cardiovascular Disease has now become the most expensive chronic medical condition. As of 2014, heart failure and stroke rank as the costliest chronic conditions in the Medicare fee-for-service program. In 2016, costs associated with CVDs amounted to a staggering $555 billion, and this figure is projected to exceed $1.1 trillion by 2035, surpassing estimates for other chronic diseases like diabetes and Alzheimer’s disease.

The substantial cost increase is primarily attributed to the aging population, particularly the baby boomer generation. By 2035, CVD-related expenses are expected to more than triple for individuals aged 80 and older and more than double for those aged 65 to 79. Thus, CVD will maintain its position as the most financially burdensome health issue in America.

No Silver Bullet for CVD: Emphasizing Both Prevention and Treatment

Effectively managing heart failure patients and reducing hospitalizations is of paramount importance for patient well-being and healthcare system efficiency. Over 25% of discharged heart failure patients face readmission within the initial 30 days, resulting in poor functional capacity, exercise tolerance, and quality of life.

See also  Micro-LNG Market: A Promising Outlook for Investors

Chronic heart failure care demands a complex regimen, including multiple medications, lifestyle modifications, and interventions. Self-management can be overwhelming for patients, involving medication tracking, symptom monitoring, vital sign checks, exercise routines, and dietary adjustments.

Living Well Despite Heart Failure: The Role of Mobile Apps

To assist patients in self-managing their condition, there is a growing array of mobile apps available. These apps enable patients to monitor symptoms, vital signs, and physical activity, as well as track medication schedules and follow treatment plans. They also facilitate communication with healthcare professionals, enhancing the overall quality of care.

However, experts emphasize that clinical outcomes in heart failure are not only dependent on technology but also on patients’ knowledge, self-management skills, and readiness to seek early care for symptoms. Patients must actively engage in their health management, leveraging mobile apps as tools for better self-care.

Wearable Technologies Aid Patient Monitoring

Wearable devices equipped with advanced software and artificial intelligence are being developed to detect abnormal heart rates, arrhythmias, and other factors, providing patients with early warnings and facilitating timely intervention.

Healthcare delivery systems are evolving to meet the demands for flexibility, interactivity, and portability. Medical device manufacturers are developing wireless-enabled devices and mobile apps that allow remote monitoring of patient vital signs and other critical information, ensuring more efficient and cost-effective care.

Regulations and Compliance

To ensure patient safety, health-related software and applications are subject to rigorous regulatory standards. These include international standards like EN/IEC 62304, the FDA’s regulations in the United States, and EU regulations such as Article 2(1) of Regulation (EU) 2017/745 (MDR) and Article 2(2) of Regulation (EU) 2017/746 (IVDR).

Major Heart Failure Software Companies

Numerous companies are at the forefront of developing innovative solutions for heart failure management, including Cardiawave, CardioDx, Cardiologs, CardioSmart Heart Explorer, CVRx, Eko, Bardy Diagnostics, ElectroMap, Heartbeat, HF Path™, Heart Failure Storylines, Heart Health Intelligence, KardiaSoft, Magicardio, Medly App, My Cardiac Coach, my mHealth, OtiTopic, Pam+, PatientConnect, Sensible Medical, Sentinel, Sky Labs, TreatHF, Vector, Verily, and VoxelCloud.

See also  Oxo Alcohol Market: Expanding Applications Fuel Steady Growth

As the global burden of Cardiovascular Diseases continues to rise, it is imperative for healthcare systems, technology companies, and patients to work collaboratively to combat this pressing health threat.

Global Industry Analysis (2018 – 2021) – Growth Trends and Market Forecast (2022 – 2029)

Visit Our Blogs:

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.


Fairfield Market Research

London, UK

UK +44 (0)20 30025888

USA (Toll-free) +1 (844) 3829746


LinkedIn | Twitter

This press release first seen on Brilad